human clinical trials Archives

Parkinson’s Stem Cell Trial: What Happened After One Year?

Key Takeaways A one-year Parkinson’s stem cell trial called STEM-PD found no serious side effects linked to the cell product itself. Scientists used embryonic stem cells to grow dopamine producing cells, then transplanted them into eight patients with Parkinson’s disease. Six of seven surviving patients cut their Parkinson’s medication substantially,

September 16, 2026 No Comments

How Mesenchymal Stem Cells May Help Immune Balance in Relapsing-Remitting MS

Quick Summary Mesenchymal stem cells (MSCs) help regulate immune responses in relapsing-remitting MS by interacting with immune cells, reducing inflammation, and providing neuroprotective effects. Unlike traditional immunosuppressive treatments, MSCs promote balanced immune modulation and may offer long-term stability with a favorable safety profile. How MSCs work: Interact with T cells

April 30, 2026 No Comments